| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.37 | 0.07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |